188 related articles for article (PubMed ID: 14967536)
1. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
Gupta AK; Curtis AS
Biomaterials; 2004 Jul; 25(15):3029-40. PubMed ID: 14967536
[TBL] [Abstract][Full Text] [Related]
2. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
Gupta AK; Berry C; Gupta M; Curtis A
IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
[TBL] [Abstract][Full Text] [Related]
3. Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture.
Gupta AK; Curtis AS
J Mater Sci Mater Med; 2004 Apr; 15(4):493-6. PubMed ID: 15332623
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles.
Gupta AK; Gupta M
Biomaterials; 2005 May; 26(13):1565-73. PubMed ID: 15522758
[TBL] [Abstract][Full Text] [Related]
5. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.
Petri-Fink A; Chastellain M; Juillerat-Jeanneret L; Ferrari A; Hofmann H
Biomaterials; 2005 May; 26(15):2685-94. PubMed ID: 15585272
[TBL] [Abstract][Full Text] [Related]
6. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
Berry CC; Wells S; Charles S; Curtis AS
Biomaterials; 2003 Nov; 24(25):4551-7. PubMed ID: 12950997
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
Gupta AK; Gupta M
Biomaterials; 2005 Jun; 26(18):3995-4021. PubMed ID: 15626447
[TBL] [Abstract][Full Text] [Related]
8. Cell response to dextran-derivatised iron oxide nanoparticles post internalisation.
Berry CC; Wells S; Charles S; Aitchison G; Curtis AS
Biomaterials; 2004 Oct; 25(23):5405-13. PubMed ID: 15130725
[TBL] [Abstract][Full Text] [Related]
9. The influence of elastin-coated 520-nm- and 20-nm-diameter nanoparticles on human fibroblasts in vitro.
Berry CC; Rudershausen S; Teller J; Curtis AS
IEEE Trans Nanobioscience; 2002 Sep; 1(3):105-9. PubMed ID: 16696299
[TBL] [Abstract][Full Text] [Related]
10. Superparamagnetic iron oxide nanoparticles change endothelial cell morphology and mechanics via reactive oxygen species formation.
Buyukhatipoglu K; Clyne AM
J Biomed Mater Res A; 2011 Jan; 96(1):186-95. PubMed ID: 21105167
[TBL] [Abstract][Full Text] [Related]
11. In-vitro cytotoxicity and cell uptake study of gelatin-coated magnetic iron oxide nanoparticles.
Gaihre B; Hee Lee Y; Khil MS; Yi HK; Kim HY
J Microencapsul; 2011; 28(4):240-7. PubMed ID: 21545315
[TBL] [Abstract][Full Text] [Related]
12. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
13. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.
Kohler N; Sun C; Wang J; Zhang M
Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications.
Lin JJ; Chen JS; Huang SJ; Ko JH; Wang YM; Chen TL; Wang LF
Biomaterials; 2009 Oct; 30(28):5114-24. PubMed ID: 19560199
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated targeted delivery of DNA using Lactoferrin nanoparticles.
Kumari S; Kondapi AK
Int J Biol Macromol; 2018 Mar; 108():401-407. PubMed ID: 29191424
[TBL] [Abstract][Full Text] [Related]
17. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications.
Amstad E; Textor M; Reimhult E
Nanoscale; 2011 Jul; 3(7):2819-43. PubMed ID: 21629911
[TBL] [Abstract][Full Text] [Related]
18. Characterization of interaction of magnetic nanoparticles with breast cancer cells.
Calero M; Chiappi M; Lazaro-Carrillo A; RodrÃguez MJ; Chichón FJ; Crosbie-Staunton K; Prina-Mello A; Volkov Y; Villanueva A; Carrascosa JL
J Nanobiotechnology; 2015 Feb; 13():16. PubMed ID: 25880445
[TBL] [Abstract][Full Text] [Related]
19. Characterization of aqueous dispersions of Fe(3)O(4) nanoparticles and their biomedical applications.
Cheng FY; Su CH; Yang YS; Yeh CS; Tsai CY; Wu CL; Wu MT; Shieh DB
Biomaterials; 2005 Mar; 26(7):729-38. PubMed ID: 15350777
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells.
Kumar CS; Leuschner C; Doomes EE; Henry L; Juban M; Hormes J
J Nanosci Nanotechnol; 2004 Mar; 4(3):245-9. PubMed ID: 15233083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]